SOLEX(SH:603992)2023-10-29 16:00Financial Performance - The company's operating revenue for Q3 2023 was CNY 798,683,232.46, representing a year-on-year increase of 3.14% compared to CNY 774,369,834.86 in the same period last year[8]. - Net profit attributable to shareholders for Q3 2023 reached CNY 183,588,738.74, a significant increase of 151.88% from CNY 72,864,714.94 in the previous year[8]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 156,727,198.85, up 82.65% from CNY 85,781,922.55 in the same period last year[8]. - Basic earnings per share for Q3 2023 were CNY 0.46, reflecting a 155.56% increase compared to CNY 0.18 in the same period last year[8]. - The weighted average return on equity increased to 8.23%, up 3.54 percentage points from 3.06% in the previous year[8]. - Total operating revenue for the first three quarters of 2023 was CNY 2,193,627,924.26, a decrease of 11.73% compared to CNY 2,485,942,813.31 in the same period of 2022[25]. - Net profit for the first three quarters of 2023 reached CNY 334,700,584.46, an increase of 37.83% compared to CNY 242,880,942.30 in the same period of 2022[26]. - The total comprehensive income attributable to the parent company for Q3 2023 was CNY 304,030,009.27, an increase from CNY 228,847,583.14 in Q3 2022, representing a growth of approximately 33%[27]. - Basic and diluted earnings per share for Q3 2023 were CNY 0.76, up from CNY 0.57 in Q3 2022, reflecting a year-over-year increase of about 33%[27]. Assets and Liabilities - Total assets at the end of Q3 2023 were CNY 4,393,711,506.50, a decrease of 0.53% from CNY 4,417,064,231.50 at the end of the previous year[8]. - Total liabilities decreased to CNY 1,778,773,914.13 in Q3 2023 from CNY 2,038,775,355.12 in Q3 2022, a reduction of 12.76%[22]. - The company's total assets as of the end of Q3 2023 were CNY 4,393,711,506.50, slightly down from CNY 4,417,165,140.01 at the end of Q3 2022[22]. - Shareholders' equity attributable to the parent company increased to CNY 2,400,806,034.74, representing a growth of 10.37% from CNY 2,175,201,699.00 at the end of the previous year[8]. - The total equity attributable to shareholders increased to CNY 2,400,806,034.74 in Q3 2023 from CNY 2,175,327,553.07 in Q3 2022, reflecting a growth of 10.34%[22]. Cash Flow - The net cash flow from operating activities for the year-to-date period decreased by 40.53% to CNY 298,830,687.02 compared to CNY 502,461,417.97 in the previous year[12]. - Net cash flow from operating activities for the first three quarters of 2023 was CNY 298,830,687.02, down from CNY 502,461,417.97 in the same period of 2022, indicating a decline of approximately 40%[30]. - Cash inflow from investment activities for the first three quarters of 2023 was CNY 2,107,990,986.23, significantly higher than CNY 178,261,366.25 in the same period of 2022[30]. - The net cash flow from investment activities for the first three quarters of 2023 was -CNY 137,005,180.14, an improvement compared to -CNY 735,089,279.83 in the same period of 2022[30]. - The company experienced a net cash outflow from financing activities of -CNY 99,071,728.86 in the first three quarters of 2023, a significant decrease from a net inflow of CNY 548,718,291.30 in the same period of 2022[30]. Segment Performance - Total revenue for the health hardware segment was CNY 216,156.36 million, a decrease of 10.27% compared to the same period last year[18]. - Net profit for the health hardware segment increased by 18.50% to CNY 41,065.32 million, while net profit attributable to shareholders rose by 14.28% to CNY 37,998.39 million[18]. - Revenue for the "Songlin Home" segment was CNY 3,206.43 million, down 58.36% year-over-year[19]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,918[14]. - The largest shareholder, Songlin Group Investment Co., Ltd., holds 124,751,108 shares, representing 31.11% of total shares[14]. Cash and Inventory Management - The company's cash and cash equivalents as of September 30, 2023, amounted to CNY 1,163,137,415.58, an increase from CNY 1,104,244,168.03 at the end of 2022[20]. - Total current assets increased to CNY 2,795,633,705.10 from CNY 2,511,026,326.46 at the end of 2022[20]. - The company reported a decrease in inventory to CNY 310,848,068.25 from CNY 368,948,212.31 at the end of 2022[20]. Research and Development - Research and development expenses for Q3 2023 were CNY 142,711,603.43, slightly up from CNY 142,257,312.16 in Q3 2022, indicating a focus on innovation[26]. - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[17]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[26]. Financial Expenses - The company reported a significant decrease in financial expenses, with a net financial cost of CNY -8,451,516.84 in Q3 2023 compared to CNY -47,470,305.24 in Q3 2022[26].